Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03739606
Title Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors City of Hope Medical Center

hematologic cancer

Hodgkin's lymphoma

chronic myeloid leukemia

acute leukemia

hairy cell leukemia

acute lymphoblastic leukemia



Age Groups: adult | child | senior
Covered Countries

Facility Status City State Zip Country Details
*Shaded cells indicate that there was no data available from for the field